With the analysis among 7,097 patents, we discovered top 451 key players by total patent application. Novartis AG, F. Hoffmann-La Roche Ltd., Amgen, Inc. are dominant in this area. They take 6.47% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 213
F. Hoffmann-La Roche Ltd.
California, United States
Patent: 120
Indiana, United States
Patent: 117
Hokkaido, Japan
Patent: 94
Akebia Therapeutics, Inc.
Massachusetts, United States
Patent: 83
Sanofi-Aventis Deutschland GmbH
Hessen, Germany
Patent: 79
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 76
Hessen, Germany
Patent: 76
With the analysis among 202 patents, we discovered top 39 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Goldfinch Bio, Inc., Espervita Therapeutics, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Massachusetts, United States
Patent: 29
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 13
Nacuity Pharmaceuticals, Inc.
Texas, United States
Patent: 10
Oregon, United States
Patent: 9
Kanagawa-ken, Japan
Patent: 9
Massachusetts, United States
Patent: 7
North Carolina, United States
Patent: 7
Phanes Therapeutics, Inc.
California, United States
Patent: 7
With the analysis among related 3,295 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Eli Lilly & Co., Amgen, Inc., Japan Tobacco, Inc. take 5.13% of patent filing during this period.
Indiana, United States
Patent: 75
California, United States
Patent: 50
Tokyo-to, Japan
Patent: 44
Akebia Therapeutics, Inc.
Massachusetts, United States
Patent: 43
Cambridgeshire, United Kingdom
Patent: 34
Enanta Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 32
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 32
Zhejiang Sheng, China
Patent: 30
Massachusetts, United States
Patent: 29
Basel-Stadt, Switzerland
Patent: 28
With the analysis among related 3,295 patents in last 5 years, we discover 315 new entrants. Zhejiang University, Goldfinch Bio, Inc., Chinook Therapeutics, Inc. are the most active new entrants in this area.
Zhejiang Sheng, China
Patent: 30
Massachusetts, United States
Patent: 29
Chinook Therapeutics, Inc.
Alberta, Canada
Patent: 25
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 24
Silence Therapeutics GmbH
Berlin, Germany
Patent: 19
Nippon Chemiphar Co., Ltd.
Tokyo-to, Japan
Patent: 16
undefined undefined
Patent: 16
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 13
Baden-Württemberg, Germany
Patent: 13
Principia Biopharma, Inc.
California, United States
Patent: 12
With the analysis among 1,776 patents, we discovered top 254 universities and scientific research institutions by total patent application. The Trustees of Columbia University in The City of New York, Wake Forest University, Zhejiang University are dominant in this area. They take 8.67% of the total patent filing.
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 66
North Carolina, United States
Patent: 32
Zhejiang Sheng, China
Patent: 30
LEICESTER, United Kingdom
Patent: 29
Connecticut, United States
Patent: 27
Niigata-ken, Japan
Patent: 27
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 24
Chinese Academy of Medical Scciences & Peking Union Medical College
Miyagi-ken, Japan
Patent: 20
New Hampshire, United States
Patent: 19